Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It
Antioxidants · 15.01.2025 · 14 (1) · 94
DOI: 10.3390/antiox14010094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 15.01.2025. Verfasst von Eleicy Nathaly Mendoza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, NextGenerationEU - European Union, Italian Association for Cancer Research (AIRC).
Abstract (Originalsprache)
Normal tissues typically maintain partial oxygen pressure within a range of 3–10% oxygen, ensuring homeostasis through a well-regulated oxygen supply and responsive vascular network. However, in solid tumors, rapid growth often outpaces angiogenesis, creating a hypoxic microenvironment that fosters tumor progression, altered metabolism and resistance to therapy. Hypoxic tumor regions experience uneven oxygen distribution with severe hypoxia in the core due to poor vascularization and high metabolic oxygen consumption. Cancer cells adapt to these conditions through metabolic shifts, predominantly relying on glycolysis, and by upregulating antioxidant defenses to mitigate reactive oxygen species (ROS)-induced oxidative damage. Hypoxia-induced ROS, resulting from mitochondrial dysfunction and enzyme activation, exacerbates genomic instability, tumor aggressiveness, and therapy resistance. Overcoming hypoxia-induced ROS cancer resistance requires a multifaceted approach that targets various aspects of tumor biology. Emerging therapeutic strategies target hypoxia-induced resistance, focusing on hypoxia-inducible factors, ROS levels, and tumor microenvironment subpopulations. Combining innovative therapies with existing treatments holds promise for improving cancer outcomes and overcoming resistance mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
ORCID-Profile: Eleicy Nathaly Mendoza, Fabio Ciccarone
Förderung
- Ministero dell'università e della ricerca
- NextGenerationEU - European Union
- Italian Association for Cancer Research (AIRC)
Zitieren
APA
Mendoza, E. N., Ciriolo, M. R., & Ciccarone, F. (2025). Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It. Antioxidants, 14(1), 94. https://doi.org/10.3390/antiox14010094
Vancouver
Mendoza EN, Ciriolo MR, Ciccarone F. Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It. Antioxidants. 2025;14(1):94. doi:10.3390/antiox14010094
BibTeX
@article{Mendoza2025,
author = {Mendoza, Eleicy Nathaly and Ciriolo, Maria Rosa and Ciccarone, Fabio},
title = {Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {1},
pages = {94},
doi = {10.3390/antiox14010094}
}
EUVIMED